83.100
+0,00%
2026-10-19
Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +32.2% | +52.0% | 3 / 3 | +13.8% | +0.24 pp | +4.93 pp | +56.7% | 0.00 | 4.77 | 319 | +13,8% | 113 | +32,2% | 4.77 | 9.76 | −51,1% |
| Pts | 8 | 12 | 12 | 4 | 8 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 83.100 (close price on 2026-10-19)EPS (TTM): 17.427
Financial charts
1.Revenue & growth
VND bn319Q2/26
1.Revenue & growth
VND bn319Q2/26
2.Profit & growth
VND bn113Q2/26
3.Profit mix (Penman)
VND bn559Q2/26
4.Margins & cost structure
%46.6%Q2/26
5.Returns & cash cycle
% · days319%Q2/26
6.Earnings quality & cash
VND bn402Q2/26
7.Asset structure
VND bn1.122Q2/26
8.Funding & debt health
VND bn · times1.122Q2/26
9.Revenue backlog
VND bn0,31Q2/26
10.Valuation
times · %4,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %4.316Q2/26
Adjusted EPS growth, latest quarter
32.2%
Average adjusted EPS growth, 3 quarters
52.0%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26